Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director Declaration

2nd Feb 2024 14:15

RNS Number : 8811B
Haleon PLC
02 February 2024
 

 

 

 

 

Haleon plc: Director Declaration

 

 

 

2 February 2024: In accordance with paragraph 9.6.14R of the Listing Rules of the UK Financial Conduct Authority, Haleon plc (LSE/NYSE: HLN) announces that Brian McNamara, Group Chief Executive Officer, has been appointed to the Board of Mondel?z International, Inc. (Nasdaq: MDLZ), as a Non-Executive Director with effect from 1 February 2024.

 

There is no further information to be disclosed in respect of paragraph 9.6.14.

 

 

Amanda Mellor

Company Secretary

 

 

 

 

About Haleon

Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

 

For more information, please visit www.haleon.com. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNTTMTTMTBMBAI

Related Shares:

Haleon
FTSE 100 Latest
Value8,632.33
Change89.77